Surprised that some of the interest in UCG prompted by Linc's deals have not rubbed off on Cougar's sp. Market seems to have priced the chances of Cougar pulling of a similar deal as zero. Maybe too pessimistic?
Not a whole lot of companies around the world with pilot plant experience to compete against, I would have thought.
Chances of a Lazarus with a triple bypass recovery cannot be ruled out totally. Something for the patient to consider.
Add to My Watchlist
What is My Watchlist?